92 related articles for article (PubMed ID: 6523365)
1. [Possibilities for cytochemical research on neutrophils and lymphocytes in assessing the severity of the course and the completeness of recovery in viral hepatitis B].
Vasil'ev VS
Ter Arkh; 1984; 56(10):79-80. PubMed ID: 6523365
[TBL] [Abstract][Full Text] [Related]
2. Cellular and humoral immune reactions in chronic active liver disease. II. Lymphocyte subsets and viral antigens in liver biopsies of patients with acute and chronic hepatitis B.
Eggink HF; Houthoff HJ; Huitema S; Wolters G; Poppema S; Gips CH
Clin Exp Immunol; 1984 Apr; 56(1):121-8. PubMed ID: 6713726
[TBL] [Abstract][Full Text] [Related]
3. The behaviour of T and B lymphocytes during the acute phase of viral hepatitis with positive or negative HBsAg.
Boroń P; Bobrowska E; Boroń-Kaczmarska A; Nadowska K; Szpakowicz T
Med Interne; 1981; 19(1):79-82. PubMed ID: 6972080
[No Abstract] [Full Text] [Related]
4. [Production of hepatitis B virus from peripheral blood lymphocytes stimulated with phytohemagglutinin].
Sarría L; Gallego L; de las Heras B; Basaras M; Cisterna R
Enferm Infecc Microbiol Clin; 1993 Apr; 11(4):187-9. PubMed ID: 8512969
[TBL] [Abstract][Full Text] [Related]
5. [Cytochemical parameters in studying the body at peripheral hemopoiesis level].
Bazeliuk LT; Amanbekova AU; Tusupbekova GA; Mukhametzhanova RA
Med Tr Prom Ekol; 2005; (4):12-5. PubMed ID: 15921187
[TBL] [Abstract][Full Text] [Related]
6. Active rosette-forming lymphocytes in chronic hepatitis.
Stanciu L; Urcan S; Părău N; Radu D; Popescu S
Med Interne; 1982; 20(4):277-82. PubMed ID: 6985551
[TBL] [Abstract][Full Text] [Related]
7. [Lymphocyte lysosomal activity during viral hepatitis HBsAg positive].
Casirola G; Magliulo E; Marini G; Ippoliti G
Riv Emoter Immunoematol; 1975; 22(3-4):112-8. PubMed ID: 1209099
[No Abstract] [Full Text] [Related]
8. [A cytochemical study of leukocyte lipids in patients with viral hepatitis].
Nagoev BS; Tasheva DM
Lab Delo; 1989; (7):38-40. PubMed ID: 2477597
[TBL] [Abstract][Full Text] [Related]
9. [Diagnostic significance of erythrocyte carbohydrate metabolism indicators in chronic subclinical HBsAG carrier state].
Levina LD; Bezuglova IA; Proĭdakov MA
Klin Med (Mosk); 1995; 73(6):26-8. PubMed ID: 8691773
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
Kuhns MC; Kleinman SH; McNamara AL; Rawal B; Glynn S; Busch MP;
Transfusion; 2004 Sep; 44(9):1332-9. PubMed ID: 15318857
[TBL] [Abstract][Full Text] [Related]
11. Phytohemagglutin-induced lymphocyte cytotoxicity in hemodialysis patients with hepatitis B virus infection.
Huges-Law G; de Gast GC; Houwen B; The TH; Tegzess AM; van der Hem GK
Hepatogastroenterology; 1981 Apr; 28(2):93-5. PubMed ID: 7216154
[TBL] [Abstract][Full Text] [Related]
12. Detection of an acute asymptomatic HBsAg negative hepatitis B virus infection in a blood donor by HBV DNA testing.
Weber B; Mühlbacher A; Melchior W
J Clin Virol; 2005 Jan; 32(1):67-70. PubMed ID: 15572009
[TBL] [Abstract][Full Text] [Related]
13. [Prostaglandin E in acute viral hepatitis].
Davydov RR; Fokina AN; Zhukov VP; Davidovich GM
Klin Med (Mosk); 1993; 71(3):47-9. PubMed ID: 8015218
[TBL] [Abstract][Full Text] [Related]
14. [Laser nephelometric method for determining HBsAg in the serum of patients with hepatitis].
Ivanov NR; Shub GM; Mazmanidi EG
Lab Delo; 1986; (12):735-8. PubMed ID: 2434716
[No Abstract] [Full Text] [Related]
15. [Viral hepatitis associated with prolonged hemodialysis treatment].
Kiriakov Z; Patev E; Todorov K; Simeonov P; Dimitrova T
Vutr Boles; 1982; 21(4):41-6. PubMed ID: 7147918
[TBL] [Abstract][Full Text] [Related]
16. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B vaccine as a cause of false positive hepatitis B surface antigen.
Olde C; Garcia M
J CANNT; 1998; 8(4):20-1. PubMed ID: 10196927
[TBL] [Abstract][Full Text] [Related]
18. Effects of immunosuppressive therapy on viral markers in chronic active hepatitis B.
Scullard GH; Smith CI; Merigan TC; Robinson WS; Gregory PB
Gastroenterology; 1981 Dec; 81(6):987-91. PubMed ID: 7286593
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence and biochemical features of hepatitis B surface antigenemia in patients with HIV-1 infection in Lagos, Nigeria.
Iwalokun BA; Hodonu SO; Olaleye BM; Olabisi OA
Afr J Med Med Sci; 2006 Sep; 35(3):337-43. PubMed ID: 17312742
[TBL] [Abstract][Full Text] [Related]
20. KEMRI Hep-cell II hepatitis B surface antigen screening kit.
Okoth FA; Kaiguri PM; Mathenge E; Tuei J; Muchiri S; Owino N; Kamau G; Kulundu J; Njuguna A; Tukei PM; Yano M; Naruse T
East Afr Med J; 1999 Sep; 76(9):530-2. PubMed ID: 10685326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
